The Immunogenicity and Safety of 2012-2013 Trivalent Seasonal Influenza Vaccine

NCT01736709 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
202
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sinovac Biotech Co., Ltd